BlackRock Inc. Makes New $1.08 Billion Investment in Corcept Therapeutics Incorporated $CORTMarket Beat·11 hours agoCORT+0.99%BLK+1.47%
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Director Sells $12,251,409.50 in StockMarket Beat·1 day ago, 05:52 AMCORT+0.99%
Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 millionPUBT·1 day ago, 03:30 PMCORT+0.99%
Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of StockMarket Beat·Aug 19 at 04:38 AMCORT+0.99%
Corcept Chief Business Officer Gary Charles Robb sells 10,000 shares for $1.16 millionPUBT·Aug 18 at 03:31 PMCORT+0.99%
Corcept Chief Development Officer William Guyer disposes of common shares worth $1.85 millionPUBT·Aug 12 at 03:27 PMCORT+0.99%
Ten large-cap healthcare stocks with strong quant scores amid sector-wide rallyMSN·Aug 11 at 10:24 AMCORT+0.99%UNH+1.37%
12,478 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Evanson Financial LLCMarket Beat·Aug 8 at 02:56 AMCORT+0.99%RY+0.01%
Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader ChecksSimplywall·Aug 6 at 12:52 PMCORT+0.99%
Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40PUBT·Aug 5 at 05:11 PMCORT+0.99%
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its ValuationBarchart Option·Aug 4 at 01:03 PMCORT+0.99%
Jazz Pharmaceuticals (JAZZ) Q2 Earnings: What To ExpectStock Story·Aug 2 at 04:48 PMJAZZ+2.24%CORT+0.99%
Dimensional Fund Advisors LP Lowers Holdings in Corcept Therapeutics Incorporated $CORTMarket Beat·Aug 2 at 02:36 AMCORT+0.99%
Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCRrttnews·Jul 31 at 06:00 AMBAX-0.27%NEOG+1.01%